source: internationalization/trunk/TranslationSpreadsheets/WV-DIALOG-0232.txt@ 1683

Last change on this file since 1683 was 604, checked in by George Lilly, 15 years ago

Internationalization

File size: 12.3 KB
Line 
1English French Notes Complete/Exclude
2 59. WAS ENTIRE SPECIMEN SUBMITTED
3 TO PATHOLOGY..................: NA
4 60. IF MARGINS ARE FREE, WHAT IS
5 THE DISTANCE..................: NA
6 TO PATHOLOGY..................: Unknown
7 THE DISTANCE..................: Unknown
8948 59. WAS ENTIRE SPECIMEN SUBMITTED TO PATHOLOGY..................
9949 60. IF MARGINS ARE FREE, WHAT IS THE DISTANCE..................
10 61. SCOPE OF REGIONAL LYMPH NODE
11 62. NUMBER OF REGIONAL LYMPH NODES
12 63. SURGERY OF OTHER REGIONAL
13 SITE(S), DISTANT SITE(S),
14 OR DISTANT LYMPH NODE(S)......:
15 66. MICROSCOPIC STATUS OF FINAL
16 MARGIN AFTER RESECTION........: NA
17 MARGIN AFTER RESECTION........: Unknown
18 MARGIN AFTER RE-EXCISION......: NA
19 MARGIN AFTER RE-EXCISION......: Unknown
20951 66. MICROSCOPIC STATUS OF FINAL MARGIN AFTER RE-EXCISION......
21 GO TO ITEM:
22 RADIATION THERAPY
23 67. RADIATION THERAPY.............:
24 68. PRE-RADIATION THERAPY
25 MAMMOGRAM OF PATIENT..........: Not done
26 MAMMOGRAM OF PATIENT..........: Unknown if done
27952 68. PRE-RADIATION THERAPY MAMMOGRAM OF PATIENT..........
28 69. DATE RADIATION STARTED........:
29 70. DATE RADIATION ENDED..........:
30 71. SITES IRRADIATED..............:
31 72. (F) cGy DOSE TO WHOLE BREAST
32 OR CHEST WALL.................:
33 73. (F) BOOST RADIATION...........:
34361 70. DATE RADIATION ENDED..........
35953 71. SITES IRRADIATED..............
36 OR CHEST WALL.................: (Data Item for Females Only)
37 73. (F) BOOST RADIATION...........: (Data Item for Females Only)
38954 72. (F) cGy DOSE TO WHOLE BREAST OR CHEST WALL.................
39443 73. (F) BOOST RADIATION...........
40 74. REASON FOR NO RADIATION ......:
41 HORMONE THERAPY
42 75. HORMONE THERAPY...............:
43 76. DATE HORMONE THERAPY STARTED..:
44 77. (M) SPECIFIC HORMONE THERAPY..: (Data Item for Males Only)
45 77. (M) SPECIFIC HORMONE THERAPY...: None
46 77. (M) SPECIFIC HORMONE THERAPY...: Unknown
47955 77. (M) SPECIFIC HORMONE THERAPY..
48 79. DATE CHEMOTHERAPY STARTED.....:
49 80. CHEMOTHERAPEUTIC REGIME
50 CONTAINING DOXORUBICIN.......: NA, no chemotherapy
51 CONTAINING DOXORUBICIN.......: Unknown
52956 80. CHEMOTHERAPEUTIC REGIME CONTAINING DOXORUBICIN........
5381. DATE OF FIRST RECURRENCE
5482. TYPE OF FIRST RECURRENCE
5581. TYPE OF FIRST RECURRENCE
5682. DATE OF FIRST RECURRENCE
57 TABLE VI - FIRST RECURRENCE
5870 81. DATE OF FIRST RECURRENCE
5971 82. TYPE OF FIRST RECURRENCE
6083. DATE OF LAST CONTACT OR DEATH
6184. VITAL STATUS
6285. CANCER STATUS
6386. COMPLETED BY
6487. REVIEWED BY CANCER COMMITTEE
65 TABLE VII - STATUS AT LAST CONTACT
66 83. DATE OF LAST CONTACT OR DEATH..:
6715 84. VITAL STATUS...................
68 85. CANCER STATUS..................:
6981 86. COMPLETED BY...................
7082 87. REVIEWED BY CANCER COMMITTEE...
71 1. INSTITUTION ID NUMBER............: H6
72 2. ACCESSION NUMBER.................:
73 3. SEQUENCE NUMBER..................:
74 4. POSTAL CODE AT DIAGNOSIS.........:
75 5. DATE OF BIRTH....................:
76 7. SPANISH ORIGIN...................:
77 9. PRIMARY PAYER AT DIAGNOSIS.......:
7810. FAMILY HISTORY OF BREAST CANCER:
79 MATERNAL AUNT...................:
80 MATERNAL GRANDMOTHER............:
81 ONE SISTER ONLY.................:
82 MORE THAN ONE SISTER............:
83 POSTIVE FAMILY HISTORY, NOS.....:
8411. (F) PERSONAL HISTORY OF BREAST
8512. SYNCHRONOUS BREAST CANCER........:
8613. PERSONAL HISTORY OF OTHER CANCER:
8714. (F) HORMONE REPLACEMENT THERAPY..:
8815. (F) HOW MANY YEARS OF HORMONE
89 REPLACEMENT THERAPY..............:
90TABLE II - INITIAL DIAGNOSIS
9116. CLASS OF CASE....................:
9217. DIAGNOSTIC EVALUATION:
9318. (F) TYPE OF MAMMOGRAM:
94 A. MAMMOGRAM GIVEN, TYPE UNKNOWN:
95 B. SCREENING MAMMOGRAM..........:
96 C. DIAGNOSTIC MAMMOGRAM.........:
97 D. MAGNIFICAITON MAMMOGRAM......:
9819. (F) PRESENTATION OF MOST
99 DEFINITIVE MAMMOGRAM.............:
10020. DATE OF INITIAL DIAGNOSIS........:
10121. DATE OF PATHOLOGIC DIAGNOSIS.....:
10222. PRIMARY SITE (ICD-O-2)...........:
10324. BEHAVIOR CODE (ICD-O-2)..........:
10425. IF INVASIVE DUCTUAL CARCINOMA
105 REPORTED, IS DCIS ALSO PRESENT...:
10627. ARCHITECTURE PATTERN IF DCIS
107 IS PRESENT.......................:
10828. NUCLEAR GRADE IF DCIS IS
10929. DIAGNOSTIC CONFIRMATION..........:
11030. (M) LEVEL OF INVOLVEMENT:
111 CHEST WALL......................:
112 PECTORAL MUSCLES................:
113 DIAGNOSTIC AND STAGING PROCEDURES
11431. BIOPSY PROCEDURE.................:
11533. PALPABILITY OF PRIMARY...........:
11634. FIRST DETECTED BY................:
117TABLE III - TUMOR MARKERS AND PROGNOSTIC TESTS
11835. (M) DNA INDEX/PLOIDY.............:
11936. ESTROGEN RECEPTOR PROTEIN........:
12037. PROGESTERONE RECEPTOR PROTEIN....:
12138. (M) ANDROGEN RECEPTOR PROTEIN....:
12239. TYPE OF TEST.....................:
123Print Breast Cancer PCE
124(Data Item for Females Only)
125(Data Item for Males Only)
126TABLE IV - EXTENT OF DISEASE AND AJCC STAGE
12740. SIZE OF TUMOR (mm)...............:
12841. SIZE OF DCIS TUMOR (mm)..........:
12942. REGIONAL NODES EXAMINED..........:
13043. REGIONAL NODES POSITIVE..........:
131 SENTINEL NODES
13244. SENTINEL NODES BIOPSY............:
13345. NUMBER OF SENTINEL NODES
13446. NUMBER OF SENTINEL NODES
13547. SENTINEL NODE DETECTED BY........:
13648. AJCC CLINICAL STAGE (cTNM):
137 AJCC STAGE......................:
13849. AJCC PATHOLOGIC STAGE (pTNM):
13950. STAGED BY:
140 CLINICAL STAGE..................:
141 PATHOLOGIC STAGE................:
142TABLE V - FIRST COURSE OF TREATMENT
14351. DATE OF FIRST COURSE TREATMENT...:
14452. DATE OF NON CANCER-DIRECTED
14553. NON CANCER-DIRECTED SURGERY......:
14654. DATE OF (FIRST) CANCER-
147 DIRECTED SURGERY.................:
14855. SURGICAL APPROACH................:
14956. SURGERY OF PRIMARY SITE..........:
15057. SPECIMEN RADIOGRAPH..............:
15158. SURGICAL MARGINS.................:
15259. WAS ENTIRE SPECIMEN SUBMITTED
153 TO PATHOLOGY.....................:
15460. IF MARGINS ARE FREE, WHAT IS
155 THE DISTANCE.....................:
15661. SCOPE OF REGIONAL LYMPH NODE
15762. NUMBER OF REGIONAL LYMPH NODES
15863. SURGERY OF OTHER REGIONAL
159 SITE(S), DISTANT SITE(S),
160 OR DISTANT LYMPH NODE(S).........:
16166. MICROSCOPIC STATUS OF FINAL
162 MARGIN AFTER RE-EXCISION.........:
16367. RADIATION THERAPY................:
16468. PRE-RADIATION THERAPY
165 MAMMOGRAM OF PATIENT.............:
16669. DATE RADIATION STARTED...........:
16770. DATE RADIATION ENDED.............:
16871. SITES IRRADIATED.................:
16972. (F) cCy DOSE TO WHOLE BREAST
170 OR CHEST WALL....................:
17173. BOOST RADIATION..................:
17274. REASON FOR NOT RADIATION.........:
173 HORMONE THERAPY
17475. HORMONE THERAPY..................:
17576. DATE HORMONE THERAPY STARTED.....:
17677. (M) SPECIFIC HORMONE THERAPY.....:
17779. DATE CHEMOTHERAPY STARTED........:
17880. CHEMOTHERAPEUTIC REGIME
179 CONTAINING DOXORUBICIN...........:
180TABLE VI - FIRST RECURRENCE
18181. DATE OF FIRST RECURRENCE.........:
18282. TYPE OF FIRST RECURRENCE.........:
183TABLE VII - STATUS AT LAST CONTACT
18483. DATE OF LAST CONTACT OR DEATH....:
18584. VITAL STATUS.....................:
18685. CANCER STATUS....................:
18786. COMPLETED BY.....................:
18887. REVIEWED BY CANCER COMMITTEE.....:
189The Accession Year is not 1997.
190The Diagnostic Confirmation code is not 1, 2 or 4.
191There is no HISTOLOGY for this primary.
192The BEHAVIOR code is not 2 (in situ) or 3 (malignant).
193The Histology of
194 is not eligible.
1959:Print Colorectal Cancer PCE
196Patient Care Evaluation Study of Colorectal Cancer
197ACCESSION NUMBER
198SEQUENCE NUMBER
199POSTAL CODE AT DIAGNOSIS
200FAMILY HISTORY OF COLORECTAL CANCER
201PERSONAL HISTORY OF COLORECTAL CANCER
202MULTIPLE COLON/RECTUM PRIMARIES 1997
203PERSONAL HISTORY OF NON-COLORECTAL CANCER
204PREVIOUS TAH/BSO
205OTHER PRIOR CONDITIONS
206ACCESSION NUMBER.....................:
207SEQUENCE NUMBER......................:
2089POSTAL CODE AT DIAGNOSIS.............
209DATE OF BIRTH........................:
2109SPANISH ORIGIN.......................
21118PRIMARY PAYER AT DIAGNOSIS...........
212700FAMILY HISTORY OF COLORECTAL CANCER..
213701PERSONAL HISTORY OF COLORECTAL CANCER
214702MULTIPLE COLON/RECTUM PRIMARIES 1997.
215PERSONAL HISTORY OF NON-COLORECTAL CANCER:
216706 OVARIAN CARCINOMA, PERITONEAL SITE.
217710PREVIOUS TAH/BSO.....................
218OTHER PRIOR CONDITIONS:
219714 PRIOR POLYPS.......................
220DURATION OF SIGNS/SYMPTOMS PRESENT AT INITIAL DIAGNOSIS (months)
221INITIAL METHODS OF DIAGNOSIS
222REASON LEADING TO EVENTUAL DX
223DIAGNOSTIC EVALUATION
224LEVEL OF TUMOR BY ENDOSCOPIC EXAM
225LEVEL OF RECTAL TUMOR
226PRIMARY SITE
227HISTOLOGY/BEHAVIOR CODE
228DIAGNOSTIC CONFIRMATION
229TABLE II- INITIAL DIAGNOSIS
230CLASS OF CLASS...................:
231717 BOWEL OBSTRUCTION..............
232718 CHANGE IN BOWEL HABIT..........
233719 EMER PRESENTATION-OBSTRUCTION..
234722 OCCULT BLOOD ONLY IN STOOL.....
235725 RECTAL BLEEDING (MELENA).......
236INITIAL METHODS OF DIAGNOSIS:
237729 SCREENING DIGITAL RECTAL EXAM..
238730 SCREENING PHYSICAL EXAM........
239732REASON LEADING TO EVENTUAL DX....
240DIAGNOSTIC EVALUATION:
241733 BARIUM ENEMA, DOUBLE CONTRAST..
242734 BARIUM ENEMA, SINGLE CONTRAST..
243735 BARIUM ENEMA, NOS..............
244736 BIOPSY OF PRIMARY SITE.........
245737 BIOPSY OF METASTATIC SITE......
246421 CT SCAN OF CHEST...............
247738 CT SCAN OF LIVER...............
248739 CT SCAN OF PRIMARY SITE........
249741 CHEST ROENTGENOGRAM............
250743 DIGITAL RECTAL EXAM............
251744 FLEXIBLE SIGMOIDOSCOPY.........
252745 INTRAVENOUS PYELOGRAM (IVP)....
253746 SERUM-LIVER FUNCTION TEST......
254749 STOOL GUAIAC (OCCULT BLOOD)....
255752LEVEL OF TUMOR BY ENDOSCOPIC EXAM
256753LEVEL OF RECTAL TUMOR............
257PRIMARY SITE.....................:
258HISTOLOGY/BEHAVIOR CODE..........:
25926DIAGNOSTIC CONFIRMATION..........
260SIZE OF TUMOR (mm)
261CLINICAL STAGED BY
262PATHOLOGIC STAGED BY
263MARGIN OF RESECTION
264DISTANCE TO CLOSEST MUCOSAL MARGIN
265DISTANCE TO CLOSEST RADIAL MARGIN
266BLOOD VESSEL OR LYMPHATIC INVASION
267EXTRAMURAL VENOUS INVASION
268PROMINENT LYMPHOID INFILTRATE
26929SIZE OF TUMOR (mm).............
27038 AJCC STAGE...................
27119 CLINICAL STAGED BY...........
27288 AJCC STAGE...................
27389 PATHOLOGIC STAGED BY.........
274MARGIN OF RESECTION:
275754 PROXIMAL MARGIN..............
276755 DISTAL MARGIN................
277756 RADIAL MARGIN................
278757DISTANCE TO MUCOSAL MARGIN.....
279758DISTANCE TO RADIAL MARGIN......
280759BLOOD VESSEL/LYMPHATIC INVASION
281760EXTRAMURAL VENOUS INVASION.....
282761PROMINENT LYMPHOID INFILTRATE..
283PHYSICIAN PROVIDING TREATMENT
284DATE OF FIRST COURSE TREATMENT
285DATE OF INPATIENT ADMISSION
286DATE OF INPATIENT DISCHARGE
287762PHYSICIAN PROVIDING TREATMENT.....
288DATE OF FIRST COURSE TREATMENT....:
2891DATE OF INPATIENT ADMISSION.......
2901.1DATE OF INPATIENT DISCHARGE.......
291 NON CANCER-DIRECTED SURGERY DATE:
292 NON CANCER-DIRECTED SURGERY.....:
293 SURGERY OF PRIMARY SITE DATE....:
294 SURGERY OF PRIMARY SITE.........:
295 ADDITIONAL SURGICAL PROCEDURES..: NA, none performed
296 LAPAROSCOPY USED DURING SURGERY.: NA
297 METHOD OF ANASTOMOSIS...........: Not done
298 DIST OF ANASTOMOSIS FROM DENTATE: 0
299 RESIDUAL PRIMARY TUMOR..........: NA
300 OTHER SURGERY:
301 PATHOLOGICAL STATUS...........: NA
302 COMPLICATIONS AFTER FIRST COURSE OF TREATMENT:
303#################### #################### ####################
304#################### #################### ####################
305#################### #################### ####################
306#################### #################### ####################
307#################### #################### ####################
Note: See TracBrowser for help on using the repository browser.